tiprankstipranks

Kennen MacKay Profile - RBC Capital Analyst

396 Followers
tipranks
Kennen MacKay

Kennen MacKay
RBC Capital

Wall Street Analyst
#1,832 out of 12,290 Wall Street Analysts
#4,095 out of 28,763 experts

Success Rate

51%
145 out of 287 ratings made a profit

Average Return

+8.10%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Kennen MacKay's trades since 2016 and holding each position for 1 Year would result in 50.52% of your transactions generating a profit, with an average return of 8.1% per rating.

Stock Rating Distribution

553Ratings
66.73% Buy
31.65% Hold
1.63% Sell
Distribution of Kennen MacKay's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
ADC Therapeutics Ltd
(ADCT)
Rating:Buy
Date:Nov 08, 2023 - Nov 08, 2024
Return:+388.30%
The most profitable rating made by Kennen MacKay

Kennen MacKay's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Allison Transmission Holdings
Apr 27, 2016
Buy
Reiterated
$33.00
(-72.12% Downside)
1Ratings
100%
+36.30%
Kyntra Bio
Jan 18, 2017
Buy
Reiterated
$44.00
(531.28% Upside)
9Ratings
100%
+100.86%
Ultragenyx Pharmaceutical
Mar 23, 2017
Buy
Reiterated
$86.00
(269.10% Upside)
11Ratings
14%
-11.64%
Incyte
Apr 17, 2017
Buy
Reiterated
$174.00
(71.82% Upside)
9Ratings
0%
-32.30%
Tempest Therapeutics
Apr 18, 2017
Sell
Initiated
9Ratings
100%
+70.06%
ObsEva
Dec 10, 2019
Buy
Reiterated
$19.00
7Ratings
14%
-21.37%
Abeona Therapeutics
May 08, 2020
Buy
Reiterated
$7.00
(20.48% Upside)
5Ratings
20%
-40.10%
ProQR
Aug 07, 2020
Buy
Reiterated
$20.00
(1202.93% Upside)
3Ratings
33%
-21.30%
AnaptysBio
Aug 10, 2020
Hold
Reiterated
$16.00
(-69.03% Downside)
10Ratings
75%
+51.03%
Akebia Therapeutics
Sep 04, 2020
Hold
Reiterated
$5.00
(415.20% Upside)
15Ratings
0.00%
List of latest recommendations made by Kennen MacKay. Click to expand and see Kennen MacKay's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Kennen MacKay activity FAQ

What is the performance of Kennen MacKay's recommendations?
The percentage of profitable recommendations made by Kennen MacKay is 51%, and the average return per transaction is 8.10%.
    What stocks does Kennen MacKay cover?
    Kennen MacKay mostly covers BMRN ,AMGN ,AGIO stocks.
      What was Kennen MacKay's most profitable rating?
      Kennen MacKay’s most profitable ratings was a buy on ADCT stock on Nov 08, 2023 - Nov 08, 2024. The return on the trade was +388.30%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here